CureVac (CVAC) Earnings Date, Estimates & Call Transcripts

$3.02

+0.06 (+2.03%)

(As of 10/4/2024 ET)

Upcoming Earnings Date: Nov. 12Estimated
Actual EPS (Aug. 15): -$0.34 Missed By -$0.06
Consensus EPS (Aug. 15): -$0.28

CVAC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVAC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Crypto 101 Media

Next opportunity for crypto millions

The floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto. But most investors are missing the real goldmine…

Go here to discover the crypto that's about to leave Wall Street in the dust.

CureVac Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($0.14)	($0.14)	($0.14)
Q2 2024	1	($0.26)	($0.26)	($0.26)
Q3 2024	1	$1.65	$1.65	$1.65
Q4 2024	1	($0.28)	($0.28)	($0.28)
FY 2024	4	$0.97	$0.97	$0.97

CVAC Earnings Date and Information

CureVac last issued its quarterly earnings data on August 15th, 2024. The reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.06. The business earned $15.55 million during the quarter, compared to the consensus estimate of $10.07 million. CureVac has generated ($1.33) earnings per share over the last year (($1.33) diluted earnings per share). Earnings for CureVac are expected to decrease in the coming year, from $0.05 to ($0.39) per share. CureVac has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off prior year's report dates.

CureVac Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/12/2024 (Estimated)	-	-	-	-	-	-	-
8/15/2024	Q2 2024	($0.28)	($0.34)	($0.06)	($0.34)	$10.07 million	$15.55 million
5/23/2024	Q1 2024	($0.22)	($0.34)	($0.12)	($0.34)	$14.51 million	$13.43 million
4/24/2024	Q4 2023	-	($0.42)	($0.42)	($0.42)	-	$24.30 million
11/14/2023	Q3 2023	($0.26)	($0.24)	+$0.02	($0.24)	$15.01 million	$17.94 million
8/17/2023	Q2 2023	($0.28)	($0.33)	($0.05)	($0.33)	$14.89 million	$8.25 million
5/30/2023	Q1 2023	($0.29)	($0.29)	-	($0.29)	$16.45 million	$7.65 million
Get the Latest News and Ratings for CVAC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CureVac and its competitors with MarketBeat's FREE daily newsletter.
11/29/2020	Q2	($54.3660)	($0.24)	+$54.1260	-	-	-

CureVac Earnings - Frequently Asked Questions

When is CureVac's earnings date?: CureVac has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on CVAC's earnings history.
Did CureVac beat their earnings estimates last quarter?: In the previous quarter, CureVac (NASDAQ:CVAC) missed the analysts' consensus estimate of ($0.28) by $0.06 with a reported earnings per share (EPS) of ($0.34). Learn more on analysts' earnings estimate vs. CVAC's actual earnings.
How much revenue does CureVac generate each year?: CureVac (NASDAQ:CVAC) has a recorded annual revenue of $65.86 million.
How much profit does CureVac generate each year?: CureVac (NASDAQ:CVAC) has a recorded net income of -$281.58 million. CVAC has generated -$1.33 earnings per share over the last four quarters.
What is CureVac's price-to-earnings ratio?: CureVac (NASDAQ:CVAC) has a forward price-to-earnings ratio of 60.40. The price/earnings-to-growth ratio is 2.19.
What is CureVac's EPS forecast for next year?: CureVac's earnings are expected to decrease from $0.05 per share to ($0.39) per share in the next year.